MedPath

National Hepatology & Tropical Medicine Research Institute

🇪🇬Egypt
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

16

Active:0
Completed:10

Trial Phases

4 Phases

Phase 2:4
Phase 3:2
Phase 4:2
+1 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (12 trials with phase data)• Click on a phase to view related trials

Not Applicable
4 (33.3%)
Phase 2
4 (33.3%)
Phase 3
2 (16.7%)
Phase 4
2 (16.7%)

Vegetable Proteins Versus Mixed Animal Proteins on the Outcome of Hepatic Encephalopathy

Not Applicable
Not yet recruiting
Conditions
Hepatic Encephalopathy
First Posted Date
2023-10-10
Last Posted Date
2023-12-26
Lead Sponsor
National Hepatology & Tropical Medicine Research Institute
Target Recruit Count
196
Registration Number
NCT06075875
Locations
🇪🇬

NHTMRI, Cairo, Egypt

Evaluation of Perfusion Index as a Prognostication Tool for High Quality Cardiopulmonary Resuscitation

Recruiting
Conditions
Cardiac Arrest
First Posted Date
2023-10-04
Last Posted Date
2023-10-04
Lead Sponsor
National Hepatology & Tropical Medicine Research Institute
Target Recruit Count
47
Registration Number
NCT06067464
Locations
🇪🇬

NHTMRI, Cairo, Egypt

Evaluation of Perfusion Index Change Post Passive Leg Raising for Fluid Responsiveness in Critically Ill

Completed
Conditions
Fluid Responsiveness
First Posted Date
2023-10-03
Last Posted Date
2025-06-26
Lead Sponsor
National Hepatology & Tropical Medicine Research Institute
Target Recruit Count
91
Registration Number
NCT06063993
Locations
🇪🇬

NHTMRI, Cairo, Egypt

Role of Octreotide in Non Variceal Bleeding

Phase 2
Recruiting
Conditions
Non-variceal Gastrointestinal Bleeding
Interventions
First Posted Date
2023-10-02
Last Posted Date
2023-10-02
Lead Sponsor
National Hepatology & Tropical Medicine Research Institute
Target Recruit Count
56
Registration Number
NCT06062719
Locations
🇪🇬

NHTMRI, Cairo, Egypt

Assessment of Metformin as Adjuvant Therapy in Patients With Ulcerative Colitis

Phase 2
Conditions
Ulcerative Colitis
Inflammatory Bowel Diseases
Interventions
First Posted Date
2021-02-11
Last Posted Date
2021-02-11
Lead Sponsor
National Hepatology & Tropical Medicine Research Institute
Target Recruit Count
40
Registration Number
NCT04750135
Locations
🇪🇬

Tanta University Hospitals, Tanta, الغربية, Egypt

  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

News

No news found
© Copyright 2025. All Rights Reserved by MedPath